The split-virion, inactivated TIV (Fluarix® 2007/2008; GlaxoSmithKline
Biological SA, Rixensart, Belgium), contained strains of
influenza viruses that were antigenically equivalentto the annually
recommended strains of one influenza A/H1N1 virus, one A/H3N2
virus, and one B virus.
The split-virion, inactivated TIV (Fluarix® 2007/2008; GlaxoSmithKline
Biological SA, Rixensart, Belgium), contained strains of
influenza viruses that were antigenically equivalentto the annually
recommended strains of one influenza A/H1N1 virus, one A/H3N2
virus, and one B virus.
การแปล กรุณารอสักครู่..